Intranasal drug delivery: how, why and what for?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2009 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/12291 |
Resumo: | Over the recent decades the interest in intranasal delivery as a non-invasive route for drugs is increased. Since the nasal mucosa offers numerous benefits as a target tissue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. We have, herein, outlined the relevant aspects of nasal anatomy, physiology and histology, and the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation into appropriate nasal pharmaceutical formulations. |
id |
RCAP_62a26e63d00e8a9b437899b263ceb062 |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/12291 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Intranasal drug delivery: how, why and what for?Over the recent decades the interest in intranasal delivery as a non-invasive route for drugs is increased. Since the nasal mucosa offers numerous benefits as a target tissue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. We have, herein, outlined the relevant aspects of nasal anatomy, physiology and histology, and the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation into appropriate nasal pharmaceutical formulations.Fundação para a Ciência e Tecnologia POPH-QREN (SFRH/BD/45145/2008)Canadian Society for Pharmaceutical Sciences2009-10-08info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/12291http://hdl.handle.net/10316/12291engJournal of Pharmacy & Pharmaceutical Sciences. 12:3 (2009) 288-3111482-1826Pires, AnaísaFortuna, AnaAlves, GilbertoFalcão, Amílcarinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-05-25T04:13:18Zoai:estudogeral.uc.pt:10316/12291Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:47:26.568591Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Intranasal drug delivery: how, why and what for? |
title |
Intranasal drug delivery: how, why and what for? |
spellingShingle |
Intranasal drug delivery: how, why and what for? Pires, Anaísa |
title_short |
Intranasal drug delivery: how, why and what for? |
title_full |
Intranasal drug delivery: how, why and what for? |
title_fullStr |
Intranasal drug delivery: how, why and what for? |
title_full_unstemmed |
Intranasal drug delivery: how, why and what for? |
title_sort |
Intranasal drug delivery: how, why and what for? |
author |
Pires, Anaísa |
author_facet |
Pires, Anaísa Fortuna, Ana Alves, Gilberto Falcão, Amílcar |
author_role |
author |
author2 |
Fortuna, Ana Alves, Gilberto Falcão, Amílcar |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Pires, Anaísa Fortuna, Ana Alves, Gilberto Falcão, Amílcar |
description |
Over the recent decades the interest in intranasal delivery as a non-invasive route for drugs is increased. Since the nasal mucosa offers numerous benefits as a target tissue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. We have, herein, outlined the relevant aspects of nasal anatomy, physiology and histology, and the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation into appropriate nasal pharmaceutical formulations. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-10-08 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/12291 http://hdl.handle.net/10316/12291 |
url |
http://hdl.handle.net/10316/12291 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Journal of Pharmacy & Pharmaceutical Sciences. 12:3 (2009) 288-311 1482-1826 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Canadian Society for Pharmaceutical Sciences |
publisher.none.fl_str_mv |
Canadian Society for Pharmaceutical Sciences |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799133752003133440 |